Crossmark

The severity of ankylosing spondylitis and responses to anti-tumour necrosis factor biologics are not influenced by the tumour necrosis factor receptor polymorphism incriminated in multiple sclerosis

Crossref DOI link: https://doi.org/10.1038/s41435-018-0017-0

Published Online: 2018-03-10

Published Print: 2019-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Watts, Laura

Karaderi, Tugce

Roberts, Amity

Appleton, Louise

Wordsworth, Tom

Cohen, Carla

Wordsworth, Paul

Vecellio, Matteo
License Information

Text and Data Mining valid from 2018-03-10
More Information

Article History

Received: 18 September 2017

Revised: 1 December 2017

Accepted: 11 December 2017

First Online: 10 March 2018

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

Document is current

Any future updates will be listed below